Publicacions en col·laboració amb investigadors/es de Instituto de Salud Carlos III (32)

2023

  1. Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination

    Cancers, Vol. 15, Núm. 8

  2. Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19

    Cancers, Vol. 15, Núm. 20

  3. TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease

    Nature Cardiovascular Research, Vol. 2, Núm. 2, pp. 144-158

  4. The structure of Leptospira interrogans GAPDH sheds light into an immunoevasion factor that can target the anaphylatoxin C5a of innate immunity

    Frontiers in immunology, Vol. 14, pp. 1190943

2022

  1. Abundance, Betweenness Centrality, Hydrophobicity, and Isoelectric Points Are Relevant Factors in the Processing of Parental Proteins of the HLA Class II Ligandome

    Journal of Proteome Research, Vol. 21, Núm. 1, pp. 164-171

  2. Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19

    Journal of Clinical Medicine, Vol. 11, Núm. 10

  3. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

  4. Segmental undergrowth is associated with pathogenic variants in vascular malformation genes: A retrospective case-series study

    Clinical Genetics, Vol. 101, Núm. 3, pp. 296-306

  5. Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection

    Journal of Clinical Medicine, Vol. 11, Núm. 8

  6. Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster

    Cancers, Vol. 14, Núm. 22

2020

  1. Consequences of Lmna Exon 4 Mutations in Myoblast Function

    Cells, Vol. 9, Núm. 5

  2. Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection

    Biochemical Pharmacology, Vol. 182

2019

  1. Proteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected Cells

    Journal of Proteome Research, Vol. 18, Núm. 3, pp. 900-911

2018

  1. Male brown fat–Specific double knockout of IGFIR/IR: Atrophy, mitochondrial fission failure, impaired thermogenesis, and obesity

    Endocrinology, Vol. 159, Núm. 1, pp. 323-340

2017

  1. Different expression of interferon-stimulated genes in response to HIV-1 infection in dendritic cells based on their maturation state

    Journal of Virology, Vol. 91, Núm. 8

2016

  1. 8,9-Dehydrohispanolone-15,16-lactol diterpene prevents LPS-triggered inflammatory responses by inhibiting endothelial activation

    Biochemical Journal, Vol. 473, Núm. 14, pp. 2061-2071

  2. Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen

    Biochemical Pharmacology, Vol. 107, pp. 14-28

  3. Essential role of IGFIR in the onset of male brown fat thermogenic function: Regulation of glucose homeostasis by differential organ-specific insulin sensitivity

    Endocrinology, Vol. 157, Núm. 4, pp. 1495-1511

  4. IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle

    Cell Reports, Vol. 14, Núm. 9, pp. 2100-2107

2015

  1. Efecto del ácido hialurónico sobre células madre mesenquimales derivadas de tejido adiposo. Evaluación biológica in vitro

    Revista Espanola de Cirugia Ortopedica y Traumatologia, Vol. 59, Núm. 4, pp. 215-221